Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-20

FDA Approved: CLARITIN LIQUI-GELS — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

The FDA approved a supplemental application to add CLARITIN LIQUI-GELS (loratadine) as a new dosage form for Claritin. This expands the product line to include …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin Liqui-Gels (loratadine)

Snippet

SUPPL AP for CLARITIN LIQUI-GELS (LORATADINE)